ELK3 and pancreatic neoplasm: Moreover, nearly 64.3% of pancreatic cancer samples with higher expression of ZEB1 presented stronger ELK3 staining, while approximately 71.2% of those with lower ZEB1 expression exhibited weaker ELK3 staining (Figure 8C).